Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14% |
| 2 | Energy | 11.19% |
| 3 | Financials | 8.75% |
| 4 | Consumer Discretionary | 8.58% |
| 5 | Industrials | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
226
DELISTED
Immunogen Inc
IMGN
| $57.1M | 0.11% |
3,968,772
+3,029,108
| +322% | +$33.3M |
|
|
ANAC
227
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $57.1M | 0.11% |
736,962
-312,827
| -30% | -$20.5M |
|
228
Allison Transmission
ALSN
$10.1B
| $57M | 0.11% |
1,946,506
-1,957,336
| -50% | -$60.8M |
|
|
CTXS
229
DELISTED
Citrix Systems Inc
CTXS
| $56.9M | 0.11% |
1,018,105
+789,193
| +345% | +$41.9M |
|
|
PNRA
230
DELISTED
Panera Bread Co
PNRA
| $56.4M | 0.11% |
322,824
+232,929
| +259% | +$41.9M |
|
231
Align Technology
ALGN
$12B
| $56.4M | 0.11% |
899,468
+790,886
| +728% | +$46.7M |
|
232
SL Green Realty
SLG
$3.88B
| $56.4M | 0.11% |
529,866
+63,838
| +14% | +$7.49M |
|
233
Verisk Analytics
VRSK
$26.4B
| $56.3M | 0.11% |
774,082
+759,451
| +5,191% | +$55.8M |
|
234
TE Connectivity
TEL
$58.8B
| $56.1M | 0.11% |
872,268
+297,522
| +52% | +$20.6M |
|
|
VISN
235
Vistance Networks Inc
VISN
$2.66B
| $55.5M | 0.11% |
1,820,402
-48,165
| -3% | -$1.46M |
|
|
MBLY
236
DELISTED
Mobileye N.V.
MBLY
| $55.4M | 0.1% |
1,042,444
+555,550
| +114% | +$26.3M |
|
237
Neurocrine Biosciences
NBIX
$17.7B
| $55.3M | 0.1% |
1,156,887
-315,986
| -21% | -$13.4M |
|
|
CIM
238
Chimera Investment
CIM
$1.05B
| $54.9M | 0.1% |
1,333,965
+440,450
| +49% | +$19.7M |
|
239
iShares Biotechnology ETF
IBB
$9.31B
| $54.6M | 0.1% |
+443,622
| New | +$53.1M |
|
|
JNPR
240
DELISTED
Juniper Networks
JNPR
| $54.3M | 0.1% |
2,090,870
+1,951,502
| +1,400% | +$51.2M |
|
|
BRCM
241
DELISTED
BROADCOM CORP CL-A
BRCM
| $54.2M | 0.1% |
1,052,227
-1,884,502
| -64% | -$91.7M |
|
|
XLNX
242
DELISTED
Xilinx Inc
XLNX
| $54M | 0.1% |
1,221,866
+855,429
| +233% | +$38.5M |
|
243
CALL
Energy Transfer Partners
ET
$70.1B
| $53.8M | 0.1% |
1,676,600
-768,600
| -31% | -$25.7M |
|
|
AXLL
244
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $53.7M | 0.1% |
1,489,601
-1,525,933
| -51% | -$60.9M |
|
245
Reliance Steel & Aluminium
RS
$20.8B
| $53.2M | 0.1% |
879,321
+193,915
| +28% | +$12.3M |
|
|
HPP
246
Hudson Pacific Properties
HPP
$834M
| $53.1M | 0.1% |
267,432
+112,051
| +72% | +$24.1M |
|
|
ZLTQ
247
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $52.1M | 0.1% |
1,769,356
+207,916
| +13% | +$6.28M |
|
248
Xylem
XYL
$28.5B
| $51.9M | 0.1% |
1,399,583
+642,747
| +85% | +$23.4M |
|
249
Acadia Healthcare
ACHC
$3.17B
| $51.8M | 0.1% |
+661,409
| New | +$47.6M |
|
|
RHT
250
DELISTED
Red Hat Inc
RHT
| $51.8M | 0.1% |
681,900
+573,900
| +531% | +$44.1M |
|
Similar funds
Millennium Management's Q2 2015 Portfolio in Review
As of Q2 2015, Millennium Management held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Millennium Management's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Energy and Financials.
- Millennium Management's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Millennium Management added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Millennium Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Millennium Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Millennium Management's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Millennium Management opened 780 new positions and closed 1,034 in Q2 2015.
- Millennium Management's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.